Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-08

FDA Approved: POTASSIUM CHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

FDA approves a supplemental application for Potassium Chloride from PAI Holdings/PAI Pharma under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Potassium chloride (Potassium chloride)

Snippet

SUPPL AP for POTASSIUM CHLORIDE (POTASSIUM CHLORIDE)